Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2008;111:935-943
© 2008 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salihu, H. M.
Right arrow Articles by Kirby, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salihu, H. M.
Right arrow Articles by Kirby, R. S.
Related Collections
Right arrow Obstetric complications of pregnancy
Right arrow Epidemiology/public health

ORIGINAL RESEARCH

AGA-Primed Uteri Compared With SGA-Primed Uteri and the Success of Subsequent In Utero Fetal Programming

Hamisu M. Salihu, MD, PhD1,2,3, Alfred K. Mbah, PhD3, Amina P. Alio, PhD4 and Russell S. Kirby, PhD5

From the Departments of 1Epidemiology and Biostatistics and 2Obstetrics and Gynecology; 3Rhea Lawton Chiles Center for Healthy Mothers and Babies; the 4Department of Community and Family Health, University of South Florida, Tampa Florida; and the 5Department of Maternal and Child Health, University of Alabama at Birmingham, Birmingham, Alabama.

OBJECTIVE: To assess whether risk for early mortality is increased with recurrent small for gestational age (SGA) compared with nonrecurrent SGA.

METHODS: We used the Missouri maternally linked cohort data containing births from 1978–1997. We identified mothers according to four categories: 1) appropriate for gestational age (AGA)–AGA: both first and second pregnancies were AGA; 2) AGA–SGA: first pregnancy was AGA, second pregnancy outcome changed to SGA (a switch); 3) SGA–AGA: first pregnancy was SGA, second pregnancy outcome AGA (a switch); 4) SGA–SGA: both first and second pregnancies were SGA. We then compared the success of fetal programming in the second pregnancy with a switch compared with a pregnancy without a switch (AGA–SGA compared with SGA–SGA; and SGA–AGA compared with AGA–AGA). We used neonatal mortality as primary outcome with infant and postneonatal mortality as secondary outcomes.

RESULTS: Appropriate for gestational age infants from a SGA-primed uterus (SGA–AGA switch) had a 19% (odds ratio 1.19; 95% confidence interval 1.11–1.28) and 29% (odds ratio 1.29; 95% confidence interval 1.17–1.42) greater likelihood of infant and neonatal mortality, respectively, when compared with AGA infants from AGA-primed uterus (AGA–AGA; nonswitch). Approximately the same magnitude of risk elevation for neonatal and infant mortality was noted among SGA infants resulting from AGA-primed uterus (a switch) as among SGA infants from SGA-primed uterus (a nonswitch). Overall, the greatest risk of neonatal, infant, and postneonatal mortality was associated with an AGA–SGA switch.

CONCLUSION: Fetal programming switch in subsequent gestation adversely affects early survival of affected infants compared with those with no change in fetal growth pattern.

LEVEL OF EVIDENCE: II







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Obstetricians and Gynecologists.